1UPRES-EA 1033, IFR-118 Proteomics, Post-translational Modifications, and Glycobiology, University of Sciences and Technologies, Lille, 59650 Villeneuve d'Ascq Cedex, France. hubert.hondermarck@univ-lille1.fr
Proteomics offers new biomedical tools for identifying disease markers and drug targets. However, biological complexity presents significant challenges for proteomic research, as seen in breast cancer studies.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: